Solid-state NMR of the influenza M2 protein in lipid bilayers
脂质双层中流感 M2 蛋白的固态 NMR
基本信息
- 批准号:8894893
- 负责人:
- 金额:$ 28.54万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-09-30 至 2016-07-31
- 项目状态:已结题
- 来源:
- 关键词:AmantadineAmantadine resistanceAntiviral AgentsBindingBinding SitesBiological ModelsC-terminalChemicalsCholesterolCytoplasmic TailDependenceDevelopmentDiffusionDrug Binding SiteFlu virusFundingFutureGated Ion ChannelHydrogen BondingImidazoleImmune systemInfluenzaInfluenza A Virus, H1N1 SubtypeIon ChannelIon TransportKnowledgeLeadLengthLeukocytesLipid BilayersM2 proteinMagicMeasurementMeasuresMediatingMembraneMembrane LipidsModelingMolecularMolecular ConformationMolecular StructureMutationPharmaceutical PreparationsPotassium ChannelProtein DynamicsProteinsProtonsRelaxationResearch ProposalsResolutionRimantadineStructureTechniquesTestingTransmembrane DomainVariantVertebral columnVirionVirusVirus AssemblyVirus DiseasesWorkabstractingbasechelationcombatdeprotonationdimerfluinfluenzavirusinhibitor/antagonistinsightpandemic diseasepandemic influenzapreventprotein complexprotonationresearch studysolid state nuclear magnetic resonancethree dimensional structurevoltage
项目摘要
Abstract
The influenza M2 protein forms a pH-activated proton channel that is essential for the virus
lifecycle. Inhibition of the H+ channel activity by the amantadine class of antiviral drugs has
been made ineffective by mutations in the M2 transmembrane domain. High-resolution structure
determination of M2 is thus paramount for developing new antiviral drugs to target amantadine-
resistant M2 variants. This small protein contains all the machinery necessary for pH activation,
H+ selectivity, and gating, and is thus an excellent model system for understanding larger
voltage-gated H+ channels and pH-gated ion channels. Work funded by this research proposal
has previously led to the elucidation of the pharmacologically relevant drug-binding site in M2
and revealed pH-dependent dynamics of the proton-selective residue, His37. However, new H+
conduction models have since been proposed, and the structure basis for channel gating by Trp41
has not been studied. Aim 1 of this proposal is to elucidate the H+ conduction mechanism of M2
by examining His37 structure at acidic pH when the channel is activated. H-bonding,
protonation/deprotonation dynamics, and the effects of inhibitors on His37 structure will be
measured. Both amantadine and Cu2+ will be used as inhibitors. Aim 2 is to elucidate Trp41
structure and interaction with His37 by measuring chemical shifts and inter-atomic distances. In
addition to the H+ channel activity, M2 mediates virus budding by causing membrane curvature
in a cholesterol-dependent fashion. We will investigate M2-membrane and M2-cholesterol
interactions by distance and relaxation NMR measurements. Aim 3 will measure whether M2
preferentially binds to highly curved regions of the membrane. M2 interacts with the matrix
protein M1 through its cytoplasmic tail during virus assembly and budding. No structural
information is yet available for the cytoplasmic domain. In aim 4 we will determine the 3D
structure of full-length M2 in lipid bilayers using multidimensional MAS correlation
experiments.
抽象的
流感M2蛋白形成pH激活的质子通道,这对于病毒至关重要
生命周期。抑制抗病毒药物类肿瘤类药物的H+通道活性已有
因M2跨膜结构域突变而无效。高分辨率结构
因此,M2的确定对于开发新的抗病毒药以靶向氨酰胺 -
抗性M2变体。这种小蛋白质包含pH激活所需的所有机械,
H+选择性和门控,因此是理解较大的绝佳模型系统
电压门控的H+通道和pH门控离子通道。该研究建议资助的工作
以前已导致在M2中阐明了与药理相关的药物结合位点
并揭示了质子选择残基His37的pH依赖性动力学。但是,新的H+
此后提出了传导模型,以及TRP41的通道门控的结构基础
尚未研究。该建议的目标1是阐明M2的H+传导机制
通过检查通道激活时在酸性pH时检查HIS37结构。 h键,
质子化/去质子化动力学以及抑制剂对HIS37结构的影响将是
测量。 amantadine和Cu2+均将用作抑制剂。目标2是阐明TRP41
通过测量化学位移和原子间距离,与HIS37的结构和相互作用。在
除H+通道活性外,M2通过引起膜曲率介导病毒萌芽
以胆固醇依赖的方式。我们将研究M2膜和M2-胆固醇
通过距离和放松NMR测量的相互作用。 AIM 3将衡量M2是否
优先结合膜的高度弯曲区域。 M2与矩阵相互作用
在病毒组装和萌芽过程中,蛋白M1通过其细胞质尾巴。没有结构
信息可用于细胞质结构域。在AIM 4中,我们将确定3D
使用多维MAS相关性脂质双层中全长M2的结构
实验。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Mei Hong其他文献
Mei Hong的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Mei Hong', 18)}}的其他基金
Tau structure and dynamics in Alzheimer's disease
阿尔茨海默病中的 Tau 结构和动力学
- 批准号:
10659553 - 财政年份:2018
- 资助金额:
$ 28.54万 - 项目类别:
Molecular structures of tau aggregates studied by solid-state NMR
通过固态核磁共振研究 tau 聚集体的分子结构
- 批准号:
10230898 - 财政年份:2018
- 资助金额:
$ 28.54万 - 项目类别:
Solid-state NMR of the influenza M2 protein in lipid bilayers
脂质双层中流感 M2 蛋白的固态 NMR
- 批准号:
8508272 - 财政年份:2009
- 资助金额:
$ 28.54万 - 项目类别:
Solid-state NMR of the influenza M2 protein in lipid bilayers
脂质双层中流感 M2 蛋白的固态 NMR
- 批准号:
9231933 - 财政年份:2009
- 资助金额:
$ 28.54万 - 项目类别:
Solid-state NMR of influenza M2 protein in lipid bilayers
脂质双层中流感 M2 蛋白的固态 NMR
- 批准号:
7939909 - 财政年份:2009
- 资助金额:
$ 28.54万 - 项目类别:
Structures and Dynamics of Proton and Cation-Dependent Channels and Transporters
质子和阳离子依赖性通道和转运蛋白的结构和动力学
- 批准号:
10659039 - 财政年份:2009
- 资助金额:
$ 28.54万 - 项目类别:
Structures and Dynamics of Proton and Cation-Dependent Channels and Transporters
质子和阳离子依赖性通道和转运蛋白的结构和动力学
- 批准号:
10296879 - 财政年份:2009
- 资助金额:
$ 28.54万 - 项目类别:
Quadruple-resonance HFXY 1.3 mm CP-MAS probe for a solid-state NMR wide-bore magnet
用于固态 NMR 大口径磁体的四共振 HFXY 1.3 mm CP-MAS 探头
- 批准号:
10798817 - 财政年份:2009
- 资助金额:
$ 28.54万 - 项目类别:
Solid-state NMR of the influenza M2 protein in lipid bilayers
脂质双层中流感 M2 蛋白的固态 NMR
- 批准号:
9306548 - 财政年份:2009
- 资助金额:
$ 28.54万 - 项目类别:
相似海外基金
Targeting Viroporins and Coronavirus M Protein
靶向病毒孔蛋白和冠状病毒 M 蛋白
- 批准号:
10512629 - 财政年份:2022
- 资助金额:
$ 28.54万 - 项目类别:
Development of 4-(aroylamino)piperidine-based entry inhibitors as anti-influenza therapeutics
开发基于 4-(芳酰氨基)哌啶的进入抑制剂作为抗流感疗法
- 批准号:
10256145 - 财政年份:2021
- 资助金额:
$ 28.54万 - 项目类别:
Development of 4-(aroylamino)piperidine-based entry inhibitors as anti-influenza therapeutics
开发基于 4-(芳酰氨基)哌啶的进入抑制剂作为抗流感疗法
- 批准号:
10576494 - 财政年份:2021
- 资助金额:
$ 28.54万 - 项目类别:
Development of 4-(aroylamino)piperidine-based entry inhibitors as anti-influenza therapeutics
开发基于 4-(芳酰氨基)哌啶的进入抑制剂作为抗流感疗法
- 批准号:
10618383 - 财政年份:2021
- 资助金额:
$ 28.54万 - 项目类别:
Proton Conduction Pathways in Proton Channel Proteins
质子通道蛋白中的质子传导途径
- 批准号:
10244955 - 财政年份:2020
- 资助金额:
$ 28.54万 - 项目类别: